Cannabigerol

Cannabigerol, commonly known as CBG, is one of the many cannabinoids found in the cannabis plant. While CBD and THC have dominated the conversation, CBG, which comes primarily from young cannabis plants, is gaining traction. This cannabinoid is often referred to as the "mother of all cannabinoids" because other cannabinoids, including CBD and THC, originate from its acidic form, cannabigerolic acid (CBGA).

Product Name: Cannabigerol
INCI Name: Cannabigerol
Product Code: YNR®CBG
CAS No.: 25654-31-3
Formula: C21H32O2
Functions: Anti-inflammatory, Antibacterial, Antioxidant,Relief Pain,

Product Detail

product details

product description

Cannabigerol, commonly known as CBG, is one of the many cannabinoids found in the cannabis plant. While CBD and THC have dominated the conversation, Cannabigerol, which comes primarily from young cannabis plants, is gaining traction. This cannabinoid is often referred to as the "mother of all cannabinoids" because other cannabinoids, including CBD and THC, originate from its acidic form, cannabigerolic acid (CBGA).

Cannabigerol occupies a unique position in the cannabis world. Unlike THC, which is known for its psychoactive properties, and CBD, which has been extensively researched for its health benefits, Cannabigerol is still in its early stages of research. However, preliminary studies suggest that Cannabigerol could offer a number of health benefits, from pain management to neuroprotection.

Cannabigerol is a non-psychoactive cannabinoid, which means that it does not produce the "high" associated with THC. It is extracted from the cannabis plant, specifically from its early stages of growth. As the cannabis plant matures, Cannabigerol converts to other cannabinoids, leaving only traces in mature plants.

Cannabigerol works by interacting with the human body's endocannabinoid system (ECS). The ECS plays a crucial role in regulating various physiological processes, including mood, pain perception, appetite, and more.

One of the main benefits of Cannabigerol is its non-intoxicating nature. This means that people can take advantage of its potential benefits without experiencing the "high" commonly associated with THC.
Cannabigerol shows promise in treating conditions such as irritable bowel syndrome and experimental inflammatory bowel disease. Its anti-inflammatory properties may be beneficial for conditions such as inflammatory bowel disease.

Cannabigerol has demonstrated its ability to fight bacterial strains, making it a potential candidate for antibacterial treatments. Thanks to its anti-inflammatory properties, Cannabigerol can relieve chronic pain and reduce inflammation, offering relief for conditions ranging from arthritis to migraines.

Cannabigerol's ability to interact with the body's endocannabinoid system can help manage neuropathic pain, a type of chronic pain caused by damage to the nervous system.Aside from neuropathic pain, Cannabigerol also shows promise in the treatment of inflammatory pain, further cementing its position as a potent analgesic.

It is a phytocannabinoid and a member of resorcinols. It has a role as an appetite enhancer, a plant metabolite, a cannabinoid receptor agonist, an anti-inflammatory agent, an antibacterial agent, a neuroprotective agent and an antioxidant. Pre-clinical findings show that Cannabigerol reduces intraocular pressure, possesses antioxidant, anti-inflammatory, and anti-tumoral activities, and has anti-anxiety, neuroprotective, dermatological, and appetite-stimulating effects.